Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 5th edition, 486 pages Free download

Prostate Cancer

Free Subscription 30.11.2020 1 BMC Cancer 1 Br J Cancer 1 Cancer 1 Clin Imaging 1 Eur J Radiol 1 Eur Radiol 1 Eur Urol 1 Int J Radiat Oncol Biol Phys 2 Int J Urol 2 J Magn Reson Imaging 1 J Nucl Med 4 J Urol 6 Oncogene 1 Semin Radiat Oncol 1 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. SIMMONS AD, Nguyen M, Pintus E
   Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case report.
   BMC Cancer. 2020;20:215.
   PubMed         Abstract available
   
   

   
   Br J Cancer

2. ZHAO Z, Zhao S, Luo L, Xiang Q, et al
   miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
   Br J Cancer. 2020 Nov 26. pii: 10.1038/s41416-020-01187.
   PubMed         Abstract available
   
   

   
   Cancer

3. SOHLBERG EM, Thomas IC, Yang J, Kapphahn K, et al
   Laboratory-wide association study of survival with prostate cancer.
   Cancer. 2020 Nov 25. doi: 10.1002/cncr.33341.
   PubMed         Abstract available
   
   

   
   Clin Imaging

4. PATEL N, Foster BR, Korngold EK, Jensen K, et al
   MRI of prostatic urethral mucinous urothelial carcinoma: Expanding the differential diagnosis for T2 hyperintense prostatic masses.
   Clin Imaging. 2020;68:68-70.
   PubMed         Abstract available
   
   

   
   Eur J Radiol

5. CHRISTOPHE C, Montagne S, Bourrelier S, Roupret M, et al
   Erratum to 'Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI' [Eur. J. Radiol. 132 (2020) 109350].
   Eur J Radiol. 2020 Nov 20:109417. doi: 10.1016/j.ejrad.2020.109417.
   PubMed        
   
   

   
   Eur Radiol

6. PADHANI AR, Schoots IG, Turkbey B, Giannarini G, et al
   A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis.
   Eur Radiol. 2020 Nov 25. pii: 10.1007/s00330-020-07527.
   PubMed         Abstract available
   
   

   
   Eur Urol

7. HUEBNER NA, Shariat SF
   Clinical Impact and Statistical Significance of Multiparametric Magnetic Resonance Imaging for Local Staging of Prostate Cancer.
   Eur Urol. 2020 Nov 24. pii: S0302-2838(20)30860.
   PubMed        
   
   

   
   Int J Radiat Oncol Biol Phys

8. WAGES NA, Sanders JC, Smith A, Wood S, et al
   Hypofractionated post-prostatectomy radiotherapy for prostate cancer to reduce toxicity and improve patient convenience: A Phase I/II trial.
   Int J Radiat Oncol Biol Phys. 2020 Nov 20. pii: S0360-3016(20)34497.
   PubMed         Abstract available
   
   

   
   Int J Urol

9. KATO M, Sasaki T, Inoue T
   Current experimental human tissue-derived models for prostate cancer research.
   Int J Urol. 2020 Nov 27. doi: 10.1111/iju.14441.
   PubMed         Abstract available
   
   
10. SHIRAISHI K
    Editorial Comment to Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems.
    Int J Urol. 2020 Nov 24. doi: 10.1111/iju.14446.
    PubMed        
    
    

    
    J Magn Reson Imaging

11. TONG A, Lemberskiy G, Huang C, Shanbhogue K, et al
    Exploratory study of geometric distortion correction of prostate diffusion-weighted imaging using B0 map acquisition.
    J Magn Reson Imaging. 2019 Apr 16. doi: 10.1002/jmri.26751.
    PubMed         Abstract available
    
    
12. ZANELLI E, Giannarini G, Cereser L, Zuiani C, et al
    Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.
    J Magn Reson Imaging. 2019 Apr 7. doi: 10.1002/jmri.26743.
    PubMed         Abstract available
    
    

    
    J Nucl Med

13. RAY S, Lisok A, Minn IL, Josefsson A, et al
    Preclinical evaluation of (213)Bi-/(225)Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer.
    J Nucl Med. 2020 Nov 27. pii: jnumed.120.256388. doi: 10.2967/jnumed.120.256388.
    PubMed         Abstract available
    
    

    
    J Urol

14. DEWITT-FOY ME, Gam K, Modlin C, Kim SP, et al
    Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate Cancer.
    J Urol. 2020 Nov 23:101097JU0000000000001385. doi: 10.1097/JU.0000000000001385.
    PubMed         Abstract available
    
    
15. GINSBURG KB, Cher ML, Montie JE
    Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience.
    J Urol. 2020;204:1119-1121.
    PubMed        
    
    
16. MARRA G, Zhuang J, Marquis A, Zhao X, et al
    Pain in Men Undergoing Transperineal Free-Hand Multiparametric Magnetic Resonance Imaging Fusion Targeted Biopsies under Local Anesthesia: Outcomes and Predictors from a Multicenter Study of 1,008 Patients.
    J Urol. 2020;204:1209-1215.
    PubMed         Abstract available
    
    
17. CONNOR MJ, Eldred-Evans D, van Son M, Hosking-Jervis F, et al
    A Multicenter Study of the Clinical Utility of Nontargeted Systematic Transperineal Prostate Biopsies in Patients Undergoing Pre-Biopsy Multiparametric Magnetic Resonance Imaging.
    J Urol. 2020;204:1195-1201.
    PubMed         Abstract available
    
    

    
    Oncogene

18. YADAV S, Anbalagan M, Baddoo M, Chellamuthu VK, et al
    Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians.
    Oncogene. 2020;39:4299-4311.
    PubMed         Abstract available
    
    
19. HE Y, Mi J, Olson A, Aldahl J, et al
    Androgen receptor with short polyglutamine tract preferably enhances Wnt/beta-catenin-mediated prostatic tumorigenesis.
    Oncogene. 2020;39:3276-3291.
    PubMed         Abstract available
    
    
20. ALI S, Zhang Y, Zhou M, Li H, et al
    Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis.
    Oncogene. 2020;39:1246-1259.
    PubMed         Abstract available
    
    
21. CHEN X, Xiong X, Cui D, Yang F, et al
    DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals.
    Oncogene. 2020;39:1557-1571.
    PubMed         Abstract available
    
    
22. LOVERIDGE CJ, Slater S, Campbell KJ, Nam NA, et al
    BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.
    Oncogene. 2020;39:1797-1806.
    PubMed         Abstract available
    
    
23. LI J, Pu T, Yin L, Li Q, et al
    MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness.
    Oncogene. 2020;39:3305-3321.
    PubMed         Abstract available
    
    

    
    Semin Radiat Oncol

24. O'DWYER E, Bodei L, Morris MJ
    The Role of Theranostics in Prostate Cancer.
    Semin Radiat Oncol. 2021;31:71-82.
    PubMed         Abstract available
    
    

    
    Urology

25. SCHMANKE K, Okut H, Ablah E
    Trends for Stage and Grade Group of Prostate Cancer in the US (2010-2016).
    Urology. 2020 Nov 20. pii: S0090-4295(20)31399.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: